🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

AdaptHealth reports revenue growth but misses EPS estimates

EditorRachael Rajan
Published 07/05/2024, 09:40 pm
© Reuters.
AHCO
-

PLYMOUTH MEETING - AdaptHealth Corp. (NASDAQ:AHCO), a provider of home medical equipment and related services, reported a mixed financial performance for the first quarter ended March 31, 2024, with revenue growth but a miss on earnings per share (EPS) expectations.

The company's net revenue reached $792.5 million, surpassing the analyst consensus estimate of $770.98 million and marking a 6.4% increase from the $744.6 million reported in the same quarter last year. However, AdaptHealth posted a net loss of $2.1 million, or an EPS of -$0.02, which fell short of the expected $0.06 EPS by analysts.

Adjusted EBITDA for the first quarter showed a significant improvement, rising 18.3% to $158.5 million, compared to $134.0 million in the prior year's quarter. This increase was attributed to a robust Adjusted EBITDA Margin of 20.0%.

Despite the positive revenue growth and EBITDA performance, cash flow from operations declined to $49.0 million from $140.2 million, and Free Cash Flow was negative at -$38.9 million, a decrease from $51.1 million in the first quarter of the previous year. The company noted that these decreases were primarily driven by delayed payments resulting from the Change Healthcare (NASDAQ:CHNG) data breach, but payments have largely been caught up since the end of the quarter.

Richard Barasch, Chairman and Interim CEO of AdaptHealth, expressed satisfaction with the company's first-quarter achievements, highlighting the strength of the Sleep and Respiratory product lines and the positive direction of the Diabetes product line. "We delivered 6.2% non-acquired revenue growth and an 18.3% increase in Adjusted EBITDA driven by Adjusted EBITDA Margin of 20.0%," said Barasch.

Despite the temporary challenges posed by the data breach, the company's expectations for Free Cash Flow for the first half and the full year remain unchanged. Barasch also mentioned the company's progress in reducing debt, with an expectation to be below 3x leverage in 2024.

AdaptHealth's performance reflects its position as a national leader in the healthcare-at-home market, serving approximately 4.1 million patients annually across the United States with a wide range of medical products and solutions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.